BBA
BCYC
Baker Bros. Advisors’s Bicycle Therapeutics BCYC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $75.7M | Hold |
10,885,357
| – | – | 0.73% | 18 |
|
2025
Q1 | $92.4M | Hold |
10,885,357
| – | – | 1.02% | 15 |
|
2024
Q4 | $152M | Buy |
10,885,357
+1,485,397
| +16% | +$20.8M | 1.63% | 12 |
|
2024
Q3 | $213M | Hold |
9,399,960
| – | – | 2.2% | 10 |
|
2024
Q2 | $190M | Buy |
9,399,960
+4,457,137
| +90% | +$90.2M | 2.43% | 8 |
|
2024
Q1 | $123M | Buy |
4,942,823
+3,152,433
| +176% | +$78.5M | 1.54% | 9 |
|
2023
Q4 | $32.4M | Buy |
1,790,390
+946,576
| +112% | +$17.1M | 0.37% | 32 |
|
2023
Q3 | $17M | Hold |
843,814
| – | – | 0.1% | 39 |
|
2023
Q2 | $21.5M | Hold |
843,814
| – | – | 0.12% | 41 |
|
2023
Q1 | $17.9M | Hold |
843,814
| – | – | 0.1% | 39 |
|
2022
Q4 | $25M | Hold |
843,814
| – | – | 0.15% | 35 |
|
2022
Q3 | $19.6M | Buy |
+843,814
| New | +$19.6M | 0.13% | 46 |
|